Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Impax Laboratories Inc : Impax Laboratories to Present at the UBS Global Healthcare Conference

05/20/2013 | 07:35am US/Eastern

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Investor Relations and Corporate Communications
www.impaxlabs.com


© Business Wire 2013
React to this article
Latest news on IMPAX LABORATORIES INC
05/22 IMPAX ENVIRONMENTAL MARKETS : DIRECTOR DEALINGS: Impax Environmental Director Bu..
05/20 IMPAX LABORATORIES : Reports First Quarter 2015 Financial Results
05/20 IMPAX LABORATORIES : FDA Performs GMP and Pre-Approval Inspections of Impax's Ha..
05/19 IMPAX ASSET MANAGEMENT : Managmeent Says Investments Weighed On Operating Margin
05/15 IMPAX LABORATORIES : Financial Statements and Exhibits (form 8-K/A)
05/14 IMPAX LABORATORIES : Strengthens Leadership Team by Adding New Senior Vice Presi..
05/14 IMPAX LABORATORIES : to Present at the UBS 2015 Global Healthcare Conference
05/14 IMPAX LABORATORIES : Reports FDA Performed Inspections of Impax's Hayward Facili..
05/11 IMPAX LABORATORIES : Labs reports 1Q loss
05/11 IMPAX LABORATORIES : Management's Discussion and Analysis of Results of Operatio..
Advertisement
Chart
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
More Financials